• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Aneurysm (1708)
Event Date 06/04/2020
Event Type  Injury  
Manufacturer Narrative
The author was contacted and further details were requested like event date, serial no., implant-date and possible root causes.Other code: as the device remains implanted, a further investigation of the device cannot be performed.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
Within the article ¿in situ fenestration of a dislocated bridging stent graft after multibranched endografting of a thoraco-abdominal aortic aneurysm¿ from the odosios bisdas published in the european journal of vascular endovascular surgery on june 4, 2020, (volume 60, issue 2, august 2020, page 312) the following was indicated: introduction: branched endovascular repair (bevar) is well established in the treatment of thoraco-abdominal aortic aneurysms (taaa).Despite high technical success rates, the literature reports considerable reintervention rates associated with the bridging stent grafts (brsg).One of the most challenging complications is brsg migration from the target vessel (type ic endoleak according to newer classification).An endovascular technique to address seal failure due to brsg migration that can be applied to any dislocated brsg is demonstrated.Technique: a (b)(6) year old woman underwent bevar for type iii taaa.Predischarge computed tomography angiography demonstrated a type ic endoleak at the left renal artery.The brsg, namely a gore® viabahn® vbx balloon expandable endoprosthesis (w.L.Gore, tempe, az, usa) had migrated and was lodged between the aortic wall and main body in a descending position.A 10 fr fustar steerable introducer (lifetech scientific, shenzhen, china) with a 50 mm deflectable tip, several balloons, and catheters were unsuccessfully employed to dislodge the brsg and reposition it in the left renal artery.Using an outback re-entry device (cordis, bridgewater township, nj, usa) over a 0.014¿ wire through the subclavian artery, an in situ fenestration was successfully created through the brsg with direct cannulation of the renal artery.Using balloon catheters after exchange to a rosen wire through a trailblazer support catheter (medtronic, minneapolis, mn, usa), the diameter of the fenestration was increased gradually to four mm, and a 7 mm gore® viabahn® vbx balloon expandable endoprosthesis was deployed into the renal artery.Completion angiography showed a satisfactory result despite the hourglass shape of the new brsg passing through the struts of the old one.One year follow up confirmed the patency and positioning of the second brsg.Conclusion: for failure to reposition a migrated and lodged brsg after bevar, creating an in situ fenestration on the wall of the migrated brsg by using a re-entry device and deploying a new brsg into the respective vessel is a viable bailout technique.
 
Manufacturer Narrative
H6: component code 515 added.H6: investigation conclusion and investigation findings updated.
 
Manufacturer Narrative
Attached literature article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11684503
MDR Text Key246755088
Report Number2017233-2021-01870
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeGR
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
OUTBACK RE-ENTRY DEVICE (CORDIS, BRIDGEWATER TOWNS
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-